25周年を記念 1999-2024
*3年間で¥ 153396、たったの¥ 61358
フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Filed by ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule...
Levi & Korsinsky is investigating the Board of Directors of Eclipsys Corporation (“Eclipsys” or the “Company”) (NasdaqGS: ECLP...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Eclipsys...
Filed by ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to...
Allscripts (NASDAQ: MDRX), the leading provider of clinical software, information and connectivity solutions for physicians, and...
Allscripts and Eclipsys to Merge, Creating New Healthcare Information Technology Leader $1.3 BILLION ALL-STOCK TRANSACTION TO FORM ONE COMPANY...
Eclipsys Corporation (NASDAQ:ECLP), The Outcomes Company®, today announced that the New York eHealth Collaborative Regional...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約